65862-313 : Didanosine 400 mg Delayed Release Capsule


NDC: 65862-313
Labeler: Aurobindo Pharma Limited
Product Type: Human Prescription Drug
Drug Name: Didanosine
Dosage Form: Oral Capsule, Delayed Release
Application #: ANDA090094
Rev. Date: 


Appearance:


Markings: D;09
Shapes:  Capsule
Colors:  White
Size (mm): 24
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

NDC Package Codes:

  • 65862-313-05: 500 CAPSULE, DELAYED RELEASE IN 1 BOTTLE (65862‑313‑05)
  • 65862-313-30: 30 CAPSULE, DELAYED RELEASE IN 1 BOTTLE (65862‑313‑30)
  • 65862-313-50: 10 BLISTER PACK IN 1 CARTON (65862‑313‑50) > 5 CAPSULE, DELAYED RELEASE IN 1 BLISTER PACK

Active Ingredients:

  • Didanosine

Dosage Strength:

  • 400 mg

Inactive Ingredients:

  • Sodium Starch Glycolate Type a Potato
  • Carboxymethylcellulose Sodium
  • Sodium Lauryl Sulfate
  • Hypromellose 2910 (3 Mpa.s)
  • Talc
  • Methacrylic Acid - Ethyl Acrylate Copolymer (1:1) Type a
  • Diethyl Phthalate
  • Silicon Dioxide
  • Gelatin
  • Titanium Dioxide
  • Ferrosoferric Oxide
  • Shellac

Pharmaceutical Classes:

  • Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
  • Nucleoside Analog [EXT]
  • Nucleoside Reverse Transcriptase Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 65862-092 Ddi 100 mg Chewable Tablet by Aurobindo Pharma Limited
  • 65862-093 Ddi 150 mg Chewable Tablet by Aurobindo Pharma Limited
  • 65862-094 Ddi 200 mg Chewable Tablet by Aurobindo Pharma Limited
  • 65862-109 Didanosine 10 mg/ml Oral Powder, for Solution by Aurobindo Pharma Limited
  • 65862-110 Didanosine 10 mg/ml Oral Powder, for Solution by Aurobindo Pharma Limited
  • 65862-310 Didanosine 125 mg Delayed Release Capsule by Aurobindo Pharma Limited
  • 65862-311 Didanosine 200 mg Delayed Release Capsule by Aurobindo Pharma Limited
  • 65862-312 Didanosine 250 mg Delayed Release Capsule by Aurobindo Pharma Limited
  • 0378-8886 Didanosine 125 mg Delayed Release Capsule by Mylan Pharmaceuticals Inc.
  • 0378-8887 Didanosine 200 mg Delayed Release Capsule by Mylan Pharmaceuticals Inc.
  • 0378-8888 Didanosine 250 mg Delayed Release Capsule by Mylan Pharmaceuticals Inc.
  • 0378-8889 Didanosine 400 mg Delayed Release Capsule by Mylan Pharmaceuticals Inc.
  • 0555-0588 Didanosine 200 mg Delayed Release Capsule by Barr Laboratories Inc.
  • 0555-0589 Didanosine 250 mg Delayed Release Capsule by Barr Laboratories Inc.
  • 0555-0590 Didanosine 400 mg Delayed Release Capsule by Barr Laboratories Inc.
  • 53808-0236 Didanosine 250 mg Delayed Release Capsule by State of Florida Doh Central Pharmacy
  • 53808-0353 Didanosine 400 mg Delayed Release Capsule by State of Florida Doh Central Pharmacy
  • 54868-5464 Didanosine 250 mg Delayed Release Capsule by Physicians Total Care, Inc.
  • 62584-046 Didanosine 250 mg Delayed Release Capsule by American Health Packaging
  • 62584-048 Didanosine 400 mg Delayed Release Capsule by American Health Packaging
  • More related products ...

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 65862-313 QR Code

< Prev: 65862-312Next: 65862-315 >

Related Discussions:

didanosineEC
What are side effects? ## Didanosine may cause tingling, burning or numbness in the hands and feet (peripheral neuropath... 2 replies




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.